Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Applications for the new electrochemiluminescent (ECL) and biosensor technologies.

S J Swanson1, S J Jacobs, D Mytych

  • 1Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.

Developments in Biological Standardization
|August 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mammary myofibroblastoma of the male breast: a case report and literature review.

Annals of the Royal College of Surgeons of England·2024
Same author

Global phylogenomic assessment of Leptoseris and Agaricia reveals substantial undescribed diversity at mesophotic depths.

BMC biology·2023
Same author

Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial.

AJNR. American journal of neuroradiology·2023
Same author

Comparison between Simple and Classical Techniques to Create Closed Pneumoperitoneum.

Kathmandu University medical journal (KUMJ)·2022
Same author

A new benchmark of soft X-ray transition energies of <math></math> , <math></math> , and <math></math> : paving a pathway towards ppm accuracy.

The European physical journal. D, Atomic, molecular, and optical physics·2022
Same author

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Biosensor and electrochemiluminescent (ECL) assays offer superior sensitivity and correlation compared to ELISA for monitoring cytokine levels and antibody responses. These advanced immunoassays improve cytokine therapy monitoring in preclinical and clinical trials.

Area of Science:

  • Immunology
  • Biotechnology
  • Analytical Chemistry

Background:

  • Enzyme-linked immunosorbent assays (ELISAs) have been standard for cytokine analysis.
  • Limitations of ELISAs include lower sensitivity and potential matrix effects.
  • Need for improved immunoassay techniques in cytokine research and therapy.

Purpose of the Study:

  • To evaluate biosensor and electrochemiluminescent (ECL) assays as replacements for ELISAs.
  • To assess the performance of these novel assays for cytokine level monitoring and anti-cytokine antibody detection.
  • To validate the use of BIACORE and ORIGEN Analyser systems in preclinical and clinical settings.

Main Methods:

  • Utilized BIACORE 2000 for label-free, real-time biosensor assays to detect anti-IL-10 and anti-IL-4 antibodies.

Related Experiment Videos

  • Employed ORIGEN Analyser for electrochemiluminescent (ECL) assays to quantify serum IL-10 and interferon alfa.
  • Compared performance metrics including sensitivity, throughput, and matrix effects against traditional ELISAs.

    • Main Results:

    • Biosensor assays provide real-time, label-free detection, enabling higher throughput and identification of low-affinity antibodies missed by ELISA.
    • ECL assays demonstrate enhanced sensitivity and reduced matrix effects compared to existing ELISAs for cytokine quantification.
    • Both assay types show improved correlation with biological assays.

    Conclusions:

    • Biosensor and ECL assays are effective replacements for ELISAs in monitoring cytokine levels and antibody responses.
    • These advanced immunoassays enhance the accuracy and efficiency of cytokine therapy research and clinical trials.
    • The adoption of these technologies improves the detection capabilities for critical biomarkers.